Nemanja Djokovic (Nemanja Djoković)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 16

Top Topics

Breast Cancer Risk

Histone Deacetylase

Molecular Dynamics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Archiv der Pharmazie

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Nemanja Djokovic, Ana Đurić, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Milan Beljkas, Aleksandra Ilic, Alen Cebzan, Branko Radovic, Nemanja Djokovic, Dusan Ruzic, Katarina Nikolic, Slavica Oljacic
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics 15 (11) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Nemanja Djokovic, Minna Rahnasto-Rilla, Nikolaos Lougiakis, Maija Lahtela-Kakkonen, Katarina Nikolic
SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Nemanja Djokovic, Tatjana Srdić-Rajić, Cesar Echeverria, Katarina Nikolic, Juan Francisco Santibanez
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 14 (1) (2022)
Nemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, Tatjana Srdic-Rajic, Maija K Lahtela-Kakkonen, Katarina Nikolic
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics. Journal of chemical information and modeling 62 (10) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Corentin Bon, Magdalena Barbachowska, Nemanja Djokovic, Dusan Ruzic, Yang Si, Laura Soresinetti, Corinne Jallet, Ambre Tafit, Ludovic Halby, Katarina Nikolic, Paola Barbara Arimondo
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies. Future medicinal chemistry 14 (8) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Milica Elek, Nemanja Djokovic, Annika Frank, Slavica Oljacic, Aleksandra Zivkovic, Katarina Nikolic, Holger Stark
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands. Archiv der Pharmazie 354 (6) (2021)
Corentin Bon, Yang Si, Melanie Pernak, Magdalena Barbachowska, Eva Levi-Acobas, Veronique Cadet Daniel, Corinne Jallet, Dusan Ruzic, Nemanja Djokovic, Teodora Djikic-Stojsic, Katarina Nikolic, Ludovic Halby, Paola Barbara Arimondo
Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Molecules (Basel, Switzerland) 26 (17) (2021)
Lea Albert, Jatin Nagpal, Wieland Steinchen, Lei Zhang, Laura Werel, Nemanja Djokovic, Dusan Ruzic, Malte Hoffarth, Jing Xu, Johanna Kaspareit, Frank Abendroth, Antoine Royant, Gert Bange, Katarina Nikolic, Soojin Ryu, Nils O Lindström, Lars-Oliver Essen, Olalla Vázquez
Bistable Photoswitch Allows in Vivo Control of Hematopoiesis. ACS central science 8 (1) (2021)